Worldwide Infusion Pumps Industry to 2029 - by Products, End-users, Applications and Geography


Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Infusion Pumps Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to's offering.

The global infusion pumps market is anticipated to grow at a steady pace during 2021-2029. The major factors influencing the demand for infusion pumps include growth in incidence of chronic pain, diabetes, gastrointestinal disorders and other debilitating chronic diseases and conditions. Auxiliary drivers if this market include the phenomenal rise in geriatric population pool and gradual technological developments in infusion pumps.

This report studies the global infusion pumps market in terms of four segmentation types: by products, by applications, by end-users and geography. Based on product types, the infusion pumps market is studied for volumetric pumps, syringe pumps, ambulatory, enteral, insulin, implantable, patient controlled pumps and infusion pump disposables. Infusion pumps majorly find application in chemo therapy, pediatrics, pain management, gastroenterology, hematology, diabetes management. In terms of end-users, hospitals, ambulatory care, home care, and physician office and clinics are the major usage areas for infusion pumps.

Geographically, the global infusion pumps market is classified into North America, Europe, Asia-Pacific , Middle East and Africa, Latin America regional markets. Among these, North America, Europe and Asia-Pacific markets are further studied for major country level markets; this distribution is elucidated as follows:

  • North America
  • U.S
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

Each of the segments thus mentioned are studied in terms of their market revenue (in USD Mn) for the period 2019-2029, with their respective compounded annual growth rates (CAGR %) for the forecast period 2021-2029. The market size forecast for these segments is provided while considering 2015 as the base year.

Apart for the quantitative information, this report also includes qualitative market information with respect to market dynamics: drivers, challenges and future prospects. Additionally this report also includes competitive analysis tools such as attractive investment proposition and fractal map analysis, by key players. This study concludes with company profiles section that highlights key information of the major companies engaged in manufacture and sale of infusion pumps in the international markets.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Infusion Pumps Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global Infusion Pumps Market Analysis, by Products
4.1 Preface
4.2 Volumetric Pumps
4.3 Syringe Pumps
4.4 Ambulatory
4.5 Enteral Infusion Pumps
4.6 Insulin Pumps
4.7 Implantable Pumps
4.8 Patient Controlled Pumps
4.9 Infusion Pump Disposables

Chapter 5 Global Infusion Pumps Market Analysis, by End-Users
5.1 Preface
5.2 Hospitals
5.3 Ambulatory Care
5.4 Home Care
5.5 Physician Office and Clinics

Chapter 6 Global Infusion Pumps Market Analysis, by Applications
6.1 Preface
6.2 Chemotherapy
6.3 Pediatrics
6.4 Pain Management
6.5 Gastroenterology
6.6 Hematology
6.7 Diabetes

Chapter 7 Global Infusion Pumps Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America

Chapter 8 Company Profiles
8.1 Baxter International Inc.
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 B. Braun Melsungen AG
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 CareFusion Corporation
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 Johnson & Johnson Corporation
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/Portfolio
8.4.4 News Coverage
8.5 Medtronic Plc.
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 News Coverage
8.6 Hospira
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 News Coverage
8.7 Terumo Corporation
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 News Coverage
8.8 Smiths Medical
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 News Coverage
8.9 Others

For more information about this report visit


Contact Data